' Hypercoagulation, ' Antiphospholipid Antibodies Seen in COVID-19 ' Hypercoagulation, ' Antiphospholipid Antibodies Seen in COVID-19

Marked coagulopathy and presence of antiphospholipid antibodies and cerebral infarcts in patients with COVID-19 suggest the infection represents a ' hypercoagulable ' state, experts write.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news